title: Intracavitary bleomycin vs interferon in the management of malignant pleural effusions.
authors.forename: S
authors.initials: S
authors.lastname: Sartori
authors.forename: L
authors.initials: L
authors.lastname: Trevisani
authors.forename: I
authors.initials: I
authors.lastname: Nielsen
authors.forename: D
authors.initials: D
authors.lastname: Tassinari
authors.forename: V
authors.initials: V
authors.lastname: Abbasciano
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007322:Instillation, Drug; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016066:Pleural Effusion, Malignant / Q000628:therapy*; D011994:Recombinant Proteins; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000903:Antibiotics, Antineoplastic; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012597:Sclerosing Solutions; D001761:Bleomycin